Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引:0
|
作者
Pamela C. Heaton
Vibha C. A. Desai
Christina M. L. Kelton
Swapnil N. Rajpathak
机构
[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy
[2] HealthCore,Carl H. Lindner College of Business
[3] University of Cincinnati,undefined
[4] US Outcomes Research,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源
关键词
Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
    Heaton, Pamela C.
    Desai, Vibha C. A.
    Kelton, Christina M. L.
    Rajpathak, Swapnil N.
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [2] Risk of Cardiovascular Disease Associated with Sulfonylurea or Metformin Use in Older Patients with Type 2 Diabetes
    Fu, Alex Z.
    Qiu, Ying
    Davies, Michael J.
    Engel, Samuel S.
    DIABETES, 2011, 60 : A10 - A10
  • [3] Hospital Readmission of Patients with Diabetes
    Daniel J. Rubin
    Current Diabetes Reports, 2015, 15
  • [4] Hospital Readmission of Patients with Diabetes
    Rubin, Daniel J.
    CURRENT DIABETES REPORTS, 2015, 15 (04)
  • [5] Readmission Factors of Patients with Type 2 Diabetes
    Timple, Veronica S.
    DIABETES, 2017, 66 : LB15 - LB15
  • [6] The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
    Pan, Sheng-Wei
    Yen, Yung-Feng
    Kou, Yu Ru
    Chuang, Pei-Hung
    Su, Vincent Yi-Fong
    Feng, Jia-Yih
    Chan, Yu-Jiun
    Su, Wei-Juin
    CHEST, 2018, 153 (06) : 1347 - 1357
  • [7] Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis
    Zhang, Zhen A.
    Cao, Yang
    Tao, Yujia
    Meng, E.
    Tang, Jiahao
    Liu, Yongcui
    Li, Fangping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 159
  • [8] The Clinical Course of Patients with Type 2 Diabetes Presenting to the Hospital with Sulfonylurea-Induced Hypoglycemia
    Braatvedt, Geoffrey D.
    Sykes, Adrian J.
    Panossian, Zaven
    McNeill, Dianna
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 661 - 666
  • [9] Race/Ethnic Disparities in Insulin and Sulfonylurea Use in Older Patients with Type 2 Diabetes
    Abdelgadir, Dana
    Board, Christine
    Ranatunga, Dilrini K.
    Grant, Richard W.
    DIABETES, 2022, 71
  • [10] Hospital Readmission and Emergency Department Use Based on Prescribing Patterns in Patients with Severely Uncontrolled Type 2 Diabetes Mellitus
    Lee, Phillip H.
    Franks, Andrea S.
    Barlow, Patrick B.
    Farland, Michelle Z.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (03) : 150 - 155